A Merck  Co drug shrank tumors in about  of women with an aggressive form of breast cancer in a small clinical trial an early sign of the potential of immunotherapy to treat breast tumors The Merck drug Keytruda was approved by US regulators in September to treat a deadly form of skin cancer melanoma Studies have shown the potential of Keytruda and similar drugs developed by BristolMyers Squibb Co and Roche Holding AG to treat several other types of tumors including lung cancer